A histamine H2 receptor antagonist with low toxicity that inhibits gastric acid secretion. The drug is used for the treatment of duodenal ulcers.
Nizatidine has been studied across 16 research domains including 🦠 Gut & Microbiome, 🧠 Focus & Attention, 🫁 Liver & Detox, 🔬 Inflammation, 🔥 Metabolic. The primary research focus is 🦠 Gut & Microbiome with 12% of studies addressing this area.
This evidence profile for Nizatidine is generated deterministically from 295 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.